SG11202005978RA - Method for preparing tolimidone on large scale - Google Patents
Method for preparing tolimidone on large scaleInfo
- Publication number
- SG11202005978RA SG11202005978RA SG11202005978RA SG11202005978RA SG11202005978RA SG 11202005978R A SG11202005978R A SG 11202005978RA SG 11202005978R A SG11202005978R A SG 11202005978RA SG 11202005978R A SG11202005978R A SG 11202005978RA SG 11202005978R A SG11202005978R A SG 11202005978RA
- Authority
- SG
- Singapore
- Prior art keywords
- large scale
- tolimidone
- preparing
- preparing tolimidone
- scale
- Prior art date
Links
- HJQILFPVRNHTIG-UHFFFAOYSA-N tolimidone Chemical compound CC1=CC=CC(OC2=CNC(=O)N=C2)=C1 HJQILFPVRNHTIG-UHFFFAOYSA-N 0.000 title 1
- 229950005012 tolimidone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2018/000530 WO2019139185A1 (en) | 2018-01-11 | 2018-01-11 | Method for preparing tolimidone on large scale |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202005978RA true SG11202005978RA (en) | 2020-07-29 |
Family
ID=67219718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202005978RA SG11202005978RA (en) | 2018-01-11 | 2018-01-11 | Method for preparing tolimidone on large scale |
Country Status (12)
Country | Link |
---|---|
US (1) | US11254645B2 (en) |
EP (1) | EP3737669B1 (en) |
JP (1) | JP7033662B2 (en) |
CN (1) | CN111587245B (en) |
AU (1) | AU2018401298B2 (en) |
BR (1) | BR112020013924A2 (en) |
CA (1) | CA3087085A1 (en) |
IL (1) | IL275869B1 (en) |
MX (1) | MX2020007006A (en) |
SG (1) | SG11202005978RA (en) |
WO (1) | WO2019139185A1 (en) |
ZA (1) | ZA202004851B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3922345A (en) * | 1971-10-29 | 1975-11-25 | Pfizer | Pyrimidinones and hydroxy pyrimidines |
RU2646475C2 (en) * | 2011-12-12 | 2018-03-05 | МЕЛИОР ФАРМАСЬЮТИКАЛЗ Ай, ИНК. | Treatment of type i and ii diabetes |
KR20160065496A (en) * | 2014-12-01 | 2016-06-09 | 부광약품 주식회사 | Recrystallization method for purification of phenoxy-2(1h)-pyrimidinone analogues |
KR101827744B1 (en) * | 2016-10-31 | 2018-02-09 | 부광약품 주식회사 | Method for preparing tolimidone on large scale |
-
2018
- 2018-01-11 IL IL275869A patent/IL275869B1/en unknown
- 2018-01-11 CA CA3087085A patent/CA3087085A1/en active Pending
- 2018-01-11 US US16/960,796 patent/US11254645B2/en active Active
- 2018-01-11 MX MX2020007006A patent/MX2020007006A/en unknown
- 2018-01-11 JP JP2020538803A patent/JP7033662B2/en active Active
- 2018-01-11 SG SG11202005978RA patent/SG11202005978RA/en unknown
- 2018-01-11 CN CN201880086191.4A patent/CN111587245B/en active Active
- 2018-01-11 WO PCT/KR2018/000530 patent/WO2019139185A1/en unknown
- 2018-01-11 AU AU2018401298A patent/AU2018401298B2/en active Active
- 2018-01-11 EP EP18900099.5A patent/EP3737669B1/en active Active
- 2018-01-11 BR BR112020013924-6A patent/BR112020013924A2/en active Search and Examination
-
2020
- 2020-08-05 ZA ZA2020/04851A patent/ZA202004851B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA3087085A1 (en) | 2019-07-18 |
WO2019139185A1 (en) | 2019-07-18 |
EP3737669A4 (en) | 2021-09-15 |
AU2018401298B2 (en) | 2024-04-04 |
AU2018401298A1 (en) | 2020-07-16 |
EP3737669B1 (en) | 2023-08-30 |
CN111587245B (en) | 2023-10-31 |
IL275869B1 (en) | 2024-04-01 |
EP3737669A1 (en) | 2020-11-18 |
JP2021513506A (en) | 2021-05-27 |
US11254645B2 (en) | 2022-02-22 |
JP7033662B2 (en) | 2022-03-10 |
EP3737669C0 (en) | 2023-08-30 |
BR112020013924A2 (en) | 2020-12-01 |
IL275869A (en) | 2020-08-31 |
MX2020007006A (en) | 2022-10-03 |
CN111587245A (en) | 2020-08-25 |
ZA202004851B (en) | 2022-04-28 |
US20210061772A1 (en) | 2021-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3417768C0 (en) | Method for imaging | |
GB201800298D0 (en) | Method | |
GB2588311B8 (en) | Method for preparing biochar | |
IL283331A (en) | Method for preparing n-phenylpyrazole-1-carboxamides | |
GB201800558D0 (en) | Method | |
GB2573854B (en) | Weighing system & weighing method | |
PL3733651T3 (en) | Method for producing calcobutrol | |
PT3647304T (en) | Method for preparing 2-fluoroacrylate | |
GB201820754D0 (en) | Methods for preparing compounds | |
KR102275418B9 (en) | method for preparing lithium bisfluorosulfonylimide | |
GB201800187D0 (en) | Method | |
GB201703323D0 (en) | Method for preparing polyols | |
IL282108A (en) | Preparation method for efinaconazole | |
ZA202005179B (en) | Method for preparing phloroglucinol | |
NO20200885A1 (en) | Completion system apparatus | |
ZA201903463B (en) | Method for preparing hexadecahydropyrene | |
ZA202004851B (en) | Method for preparing tolimidone on large scale | |
GB201803183D0 (en) | Method | |
GB201802653D0 (en) | Method | |
GB201801169D0 (en) | Method | |
IL271512B (en) | Method for preparing substituted 4-aminoindane derivatives | |
SG11202008179PA (en) | Method for preparing acrolein | |
GB201709297D0 (en) | Method for preparing methylprrolidones | |
PL3513886T3 (en) | Method for producing cell-connectors | |
GB2572414B (en) | Measurement method |